CCIA
CBST

Campbell & Co Investment Adviser’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-25,474
Closed -$1.78M – 293
2014
Q2 		$1.78M Buy
+25,474
New +$1.73M 0.71% 60
2013
Q4 		– Sell
-6,300
Closed -$400K – 379
2013
Q3 		$400K Buy
+6,300
New +$381K 0.08% 183

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Campbell & Co Investment Adviser's CBST Position: Q3 2014 in Review

Campbell & Co Investment Adviser sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 25,474 shares — an estimated $1.78M sold.

Campbell & Co Investment Adviser first reported a position in CBST in Q3 2013 and held it in 2 quarters. The position peaked at $1.78M in Q2 2014. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • Campbell & Co Investment Adviser reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 25,474 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.78M.
  • Campbell & Co Investment Adviser first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's CUBIST PHARMACEUTICALS INC position peaked at $1.78M in Q2 2014.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2014, filed 12 Nov 2014.